It also suppresses proliferation and invasion of breast cancer via Akt-NF-kB signaling, and inhibits patient-derived esophageal tumor growth in an in vivo mouse model via ERK1/2 inhibition [52,53,54]. Here, NFKB1 is linked to neoplasm of esophagus.